CurrentEndo
Get Weekly

Topic · page 84 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,321–3,360 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Int J Obes (Lond)

    Adipose tissue-derived metabolite risk scores and risk for type 2 diabetes in South Asians

    Cohort study

  2. Diabetes Metab

    Social isolation, loneliness, and the risk of incident type 2 diabetes mellitus by glycemic status

    Cohort study

  3. Cardiovasc Diabetol

    Association between the triglyceride-glucose index and impaired cardiovascular fitness in non-diabetic young population

    Cross-sectional study

  4. Cardiovasc Diabetol

    Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chinese adults: findings from the Da Qing Diabetes Study

    Cohort study

  5. Cardiovasc Diabetol

    Diabetes mellitus is associated to high-risk late gadolinium enhancement and worse outcomes in patients with nonischemic dilated cardiomyopathy

    Cohort study

  6. Diabetes Res Clin Pract

    Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA1c variability: A post hoc analysis of the ACCORD trial

    Secondary analysis

  7. Cardiovasc Diabetol

    Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus

    Cross-sectional study

  8. Cardiovasc Diabetol

    Plasma metabolite profile of legume consumption and future risk of type 2 diabetes and cardiovascular disease

    Cross-sectional study

  9. Diabetes Care

    Optimal Dose and Type of Physical Activity to Improve Glycemic Control in People Diagnosed With Type 2 Diabetes: A Systematic Review and Meta-analysis

    Meta-analysis

  10. Diabetes Care

    A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes

    Meta-analysis

  11. Diabetes Obes Metab

    Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial

    Randomized controlled trial

  12. Diabetes Care

    The Specialist Treatment of Inpatients: Caring for Diabetes in Surgery (STOIC-D Surgery) Trial: A Randomized Controlled Trial of Early Intervention With an Electronic Specialist-Led Model of Diabetes Care

    Randomized controlled trial

  13. Diabetes Care

    Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort

    Cohort study

  14. Diabetes Care

    Association Between Age at Diabetes Diagnosis and Subsequent Incidence of Cancer: A Longitudinal Population-Based Cohort

    Cohort study

  15. Diabetes Res Clin Pract

    Incidence and prevalence of type 2 diabetes in Manitoba children 2009–10 to 2017–18: First Nation versus all other Manitobans

    Cohort study

  16. BMJ Open Diabetes Res Care

    Effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on serum uric acid levels in patients with chronic kidney disease: a systematic review and network meta-analysis

    Meta-analysis

  17. Diabetologia

    Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study

    Secondary analysis

  18. Diabet Med

    A core outcome set for trials evaluating self‐management interventions in people with severe mental illness and coexisting type 2 diabetes

    Guideline or statement

  19. J Clin Endocrinol Metab

    Acute Exercise Increases GDF15 and Unfolded Protein Response/Integrated Stress Response in Muscle in Type 2 Diabetes

    Mechanistic study

  20. Diabetes Res Clin Pract

    Association between age at diagnosis of type 2 diabetes and cardiovascular morbidity and mortality risks: A nationwide population-based study

    Cohort study

  21. BMJ Open Diabetes Res Care

    Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus

    Cross-sectional study

  22. BMJ Open Diabetes Res Care

    Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes

    Secondary analysis

  23. Diabetes Obes Metab

    Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Post‐authorization safety study based on multinational cohorts

    Cohort study

  24. Diabetes Obes Metab

    Two years with GIOIA ‘Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes’: A prospective, multicentre, quasi‐experimental study on sodium‐glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors in diabetes clinical practice

    Cohort study

  25. Diabetes Care

    Emotional Distress Predicts Reduced Type 2 Diabetes Treatment Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

    Secondary analysis

  26. Diabetes Care

    Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes

    Cohort study

  27. Obesity (Silver Spring)

    Net prices of new antiobesity medications

    Research article

  28. Diabetes Obes Metab

    Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c

    Cohort study

  29. Diabetes Obes Metab

    Risk factor control and incident cardiovascular disease in patients with diabetes: Sex‐specific relations

    Cohort study

  30. Diabetes Obes Metab

    Socio‐economic disparities in hospital care among Dutch patients with diabetes mellitus

    Cohort study

  31. Diabetes Obes Metab

    Prusogliptin ( DBPR108 ) monotherapy in treatment‐naïve patients with type 2 diabetes: A randomized, double‐blind, active and placebo‐controlled, phase 3 study

    Randomized controlled trial

  32. Obesity (Silver Spring)

    The role of adipogenic capacity and dysfunctional subcutaneous adipose tissue in the inheritance of type 2 diabetes mellitus: cross‐sectional study

    Cross-sectional study

  33. Cardiovasc Diabetol

    Correlation between triglyceride glucose index and collateral circulation formation in patients with chronic total occlusion of coronary arteries in different glucose metabolic states

    Cohort study

  34. Cardiovasc Diabetol

    Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

    Cohort study

  35. Cardiovasc Diabetol

    Reduced thoracic skeletal muscle size is associated with adverse outcomes in diabetes patients with heart failure and reduced ejection fraction: quantitative analysis of sarcopenia by using cardiac MRI

    Cohort study

  36. Cardiovasc Diabetol

    Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states

    Case-control study

  37. J Clin Endocrinol Metab

    Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes

    Randomized controlled trial

  38. J Clin Endocrinol Metab

    Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes

    Research article

  39. Diabetologia

    Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia

    Cross-sectional study

  40. Diabetologia

    Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 3,321–3,360 of 4,758, newest first